Facultades Interdisciplinarias
Perfil Público
Facultad Interdisciplinaria de Ciencias Biológicas y de Salud
Departamento de Ciencias Químico-Biológicas
Dr. Aldo Alejandro Arvizu Flores
aldo.arvizu@unison.mx
Maestro de Tiempo Completo
SNII 1
PRODEP
Departamento de Ciencias Químico-Biológicas
Campus Hermosillo
OrcId
Scopus
Pure
Información General
Información Académica
Publicaciones
Proyectos de Investigación
Tesis Dirigidas
Publicaciones
Listado de las ultimas publicaciones de investigación científica
Ver todas las publicaciones
Inhibition Mechanism of Lecithin-Dependent Hemolysin from Vibrio parahaemolyticus by Flavonoids
Catalysts (2025)
Conjugation of Lysozyme and Epigallocatechin Gallate for Improving Antibacterial and Antioxidant Properties
Current microbiology (2024)
Binding of green tea epigallocatechin gallate to the arginine kinase active site from the brown recluse spider (Loxosceles laeta)
Heliyon (2024)
Conjugation of Lysozyme and Epigallocatechin Gallate for Improving Antibacterial and Antioxidant Properties
Current microbiology (2024)
A Food Matrix Triggers a Similar Allergic Immune Response in BALB/c Mice Sensitized with Native, Denatured, and Digested Ovalbumin
Life (2023)
Dipeptidyl Peptidase IV Inhibitory Peptides from Chickpea Proteins (Cicer arietinum L.)
Pharmaceuticals (2023)
Prevalence of Parent-Reported Food Allergy in a Mexican Pre-School Population
Journal of Clinical Medicine (2023)
Comparative kinetic characterization of the activity of glycosylated and non-glycosylated trypsin-like serine protease isolated from adults of Rhyzopertha dominica (Coleoptera: Bostrichidae) reared on the grain of three diff erent cultivars of wheat
European Journal of Entomology (2023)
Metal Ions and Chemical Modification Reagents Inhibit the Enzymatic Activity of Lecithin-Dependent Hemolysin from Vibrio parahaemolyticus
Toxins (2022)
Analysis of IgG, IgA and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccines
Transboundary and Emerging Diseases (2021)